The global biosurgery market is estimated to grow at a CAGR of 8.8% from 2016 to 2021 to reach USD 27.78 Billion by 2021. Factors such as rising number of surgeries, rising incidences of sports related injuries & spinal problems, and rising need of effective blood loss management are major factors driving the growth of this market.

Increasing clearance of biosurgery products by regulatory authorities have also led to a rise in the demand of biosurgery products. However, little-to-no reimbursements for biosurgery products may restrain the growth of biosurgery market to a certain extent. High price of biosurgery products and rising cost of surgical procedures is also expected to challenge the growth of this market to a certain extent.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownload.asp?id=166922302

In this report, the biosurgery market is segmented on the basis of product type, application, and geography. On the basis of products, the biosurgery market is segmented into surgical sealants, hemostatic agents, adhesion barriers, bone graft substitutes, and staple line reinforcement agents. The surgical sealants market is further sub-segmented into natural and synthetic/semi-synthetic sealants. The bone graft substitutes market is further sub-segmented into bone-allografts, demineralized bone matrix, bone morphogenetic proteins, and synthetic bone-grafts. On the basis of application, the biosurgery market is sub-segmented into neurological surgeries, cardiovascular surgeries, general surgeries, orthopaedic surgeries, thoracic surgeries, gynaecological surgeries, urology surgeries, and reconstructive surgeries.

Geographically, the global biosurgery market is divided into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. In 2015, North America accounted for the largest share of the global biosurgery market, followed by Europe. However, Asia-Pacific region is expected to grow at the highest rate during the forecast period majorly due to rise in health awareness, growth in per capita income, and improving healthcare infrastructure in the region.

Get Sample PDF Pages:
https://www.marketsandmarkets.com/requestsample.asp?id=166922302

Some of the prominent players in the global biosurgery market include Baxter International Inc. (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc. (Ireland), Getinge Group (Sweden), B. Braun Melsungen AG (Germany), Cryolife Inc. (U.S.), Stryker Corporation (U.S.), Hemostasis, LLC. (U.S.), and Sanofi Group (France).